FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Takeda Pharmaceutical Seeks India's Backing for Landmark Dengue Shot

By

Takeda (TYO:4502) aims to include its dengue shot in India's state immunization program after local regulators approved it, Nikkei Asia reported Wednesday, citing head of intercontinental markets Mahender Nayak.

The newly approved shot, Qdenga, works against the mosquito-borne illness and covers all four viral strains, the news daily said.

Nayak said Takeda's strategic focus is on securing national program status to maximize public access, the publication said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

India's Market Regulator Eyes Depository Receipt Framework for REITs, Public InvITs

India's market regulator has proposed allowing real estate investment trusts (REITs) and publicly listed infrastructure investment trusts (InvITs) to issue depository receipts, according to a consultation paper published on Tuesday.The Securities and Exchange Board of India (SEBI) is proposing an enabling framework for the issuance of depository receipts backed by units of REITs and publicly listed InvITs.The regulator said the instruments would allow foreign investors to trade the securities in foreign currency on permitted international exchanges.SEBI proposed amending the REIT and InvIT regulations to permit such issuances and plans to introduce a detailed framework through a separate circular.Public comments on the consultation paper are invited until Aug. 25.

^BSENifty 50
Asia

Sharetronic Data Technology Adds 150 Million Yuan in Related Party Deals

Sharetronic Data Technology (SHE:300857) said its board approved 150 million yuan in new 2026 related-party transactions with Cheng Uei Precision for Internet of Things smart terminal product sales.This raised the annual total to 350 million yuan, according to a Wednesday filing with the Shenzhen bourse.Shares of the wireless telecommunication equipment manufacturer rose 6% in recent trade.

SHE:300857
Asia

Helens International Forecasts Lower Net Profit in H1

Helens International (SGX:HLS, HKG:9869) expects to book a net profit of up to 16 million yuan, compared with an adjusted net profit of 50.3 million yuan a year earlier.Meanwhile, the company expects a revenue of up to 260 million yuan in the first half of the year, compared to 291.2 million yuan a year earlier, according to a Tuesday filing with the Singapore Exchange.The decrease in revenue is mainly due to a decline in the number of self-operated bars during the period.

HKG:9869SGX:HLS